Crocs crushes estimates: Phenom in place


Yesterday after a horrible day in the market, Crocs (NASDAQ: CROX) released its second quarter results and they were absolutely stunning. Crocs reported earnings per share of $0.58 versus consensus estimates of $0.44 on revenues of $224 million versus consensus of $192 million.The shares were trading up nearly $10 in the after market to $58. The phenomenon known as Crocs is certainly in place.

I have written several articles about Crocs since I picked up coverage of the company back in February. The stock was trading at $40, and now on a pre-stock split basis the shares are trading at $116 (Crocs had a 2-for-1 stock split effective on June 14th), nearly a triple. I have detailed that Crocs has the opportunity to be the next Nike (NYSE: NKE), which in itself continues to be a phenomenon.

I realize that many readers feel it is a passing fad and/ or the shoes are ugly -- which I will leave to the wearers' discerning tastes -- but this company is NOT a fad. With a revenue run rate approaching $1 billion, this company jettisoned the fad category about $700 million ago. Crocs is a veritable phenomenon and will continue to have superior growth characteristics. The company has indeed gone "north of the ankle" with new apparel gear and many other accessories...sound like Nike? Crocs now distributes its products with 27,000 retailers of which 15,000 are internationally based.

Crocs' distribution model will serve as the distribution-model for other new companies to emulate. The beauty of Crocs is no bricks and mortar. Crocs is a vendor to the retail stores and other selling outlets world-wide, thus keeping its costs down significantly. With the popularity and sustainability of the brand, retailers are now seeking Crocs out for distribution arrangements.

Then comes those juicy, incredible margins. One of the guiding principals of growth investing, especially with newer companies, is the operating margins (pre-tax profits) should grow over a 5 year time frame to "mature levels". Typically, younger companies have lower operating margins due to heavy investing in research and development (R&D) and/or sales and marketing (S&M), and hope to harvest those two points of leverage later in their life-cycle. Crocs has broken the rules. The operating margins are a stunning 27-28% , even hitting 30% this second quarter, and yet there has been no apparent sacrifice in R&D or S&M. In other words, Crocs is a cash machine.

The company guided Wall Street to even higher numbers for the third quarter. Management endorsed $0.58-0.62 of earnings per share on revenues of $240-250 million. The consensus was $.43 on revenues of $195 million. The company also endorsed an annual earnings per share of $1.89 to 1.93 versus consensus of $1.56. I estimate that Crocs can earn $2.50 on revenues of $1.2 billion for 2008.

Crocs stock will open around $56-57 today, up $7 from yesterday's closing price. The shares are still a buy as this company should command at least a 30-32 price-to-earnings multiple on 2008 expectations of $2.55 in earnings per share. That being said, my new price target for Crocs is $80 ... the phenomenon is in place.

Georges Yared is the CIO of Yared Investment Research.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+24.8312,656.83
NASDAQ+3.712,897.47
S&P 500+3.641,334.30

Last updated: May 16, 2012: 09:49 AM

Hot Stocks

General Electric

18.78+0.38(+2.07)

Alcoa

8.73+0.02(+0.23)

Apple Inc

554.07+0.90(+0.16)

Google Inc 'A'

619.39+8.28(+1.35)

Bank of America

7.385+0.085(+1.16)

Wal-Mart Stores

59.45+0.10(+0.17)

Exxon Mobil Corp

82.31+0.52(+0.64)

Ford

10.27+0.12(+1.18)

Citigroup

28.18+0.39(+1.40)

IBM

198.62-0.42(-0.21)

Yahoo

15.400.00(0.00)

Starbucks

53.73+0.39(+0.73)

Microsoft

30.05-0.16(-0.53)

Home Depot

49.05+0.38(+0.78)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1337176180229 ms.